Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Current and future prospects in treating multiple myeloma

Dr Sergio Giralt – Cornell University, New York, USA
Current and future prospects in treating multiple myeloma ( Dr Sergio Giralt – Cornell University, New York, USA )
21 Jul 2017

Celebrating a 10 year partnership: ecancer and the IEO

Prof Gordon McVie - Editor in Chief, ecancer
Celebrating a 10 year partnership: ecancer and the IEO ( Prof Gordon McVie - Editor in Chief, ecancer )
19 Jul 2017

Measuring Success in Indolent Disease: Discuss, Debate, Decide

Dr George Follows, Dr Christopher P Fox and Dr Graham Collins
Measuring Success in Indolent Disease: Discuss, Debate, Decide ( Dr George Follows, Dr Christopher P Fox and Dr Graham Collins )
14 Jul 2017

What’s important to patients in a non-curative setting?

Dr Graham Collins - Oxford University Hospitals NHS Foundation Trust, Oxford, UK
What’s important to patients in a non-curative setting? ( Dr Graham Collins - Oxford University Hospitals NHS Foundation Trust, Oxford, UK )
14 Jul 2017

What to do when standard treatment fails?

Dr Christopher Fox - Nottingham University Hospitals, Nottingham, UK
What to do when standard treatment fails? ( Dr Christopher Fox - Nottingham University Hospitals, Nottingham, UK )
14 Jul 2017

How do we measure treatment success?

Dr George Follows - Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
How do we measure treatment success? ( Dr George Follows - Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK )
14 Jul 2017

The challenge of approving add-on therapies for patients with metastatic cancer

Dr David Montgomery, Alexander Smith
The challenge of approving add-on therapies for patients with metastatic cancer ( Dr David Montgomery, Alexander Smith )
5 Jul 2017

Biomarker research in breast cancer

Prof Martine Piccart - Institute Jules Bordet, Brussels, Belgium
Biomarker research in breast cancer ( Prof Martine Piccart - Institute Jules Bordet, Brussels, Belgium )
4 Jul 2017

New biomarkers for response to immunotherapy

Prof Antoni Ribas - University of California, Los Angeles, USA
New biomarkers for response to immunotherapy ( Prof Antoni Ribas - University of California, Los Angeles, USA )
4 Jul 2017

Current and future immune approaches in precision medicine

Prof Jean -Yves Blay - Centre Léon Bérard, Lyon, France
Current and future immune approaches in precision medicine ( Prof Jean -Yves Blay - Centre Léon Bérard, Lyon, France )
4 Jul 2017

Precision medicine enabled histology agnostic development of immunotherapeutics

Dr Roy Baynes - Merck Research Laboratories, Rahway, USA
Precision medicine enabled histology agnostic development of immunotherapeutics ( Dr Roy Baynes - Merck Research Laboratories, Rahway, USA )
4 Jul 2017

Patient-specific peptide vaccines

Prof Hans-Georg Rammensee - University of Tübingen, Tübingen, Germany
Patient-specific peptide vaccines ( Prof Hans-Georg Rammensee - University of Tübingen, Tübingen, Germany )
4 Jul 2017